PHAARMASIA Fact Sheet, PHAARMASIA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PHAARMASIA Fact Sheet    (PHAS)


EV Stocks: Make a Fortune from Automobile Sector's Colossal Disruption


Here is the latest financial fact sheet of PHAARMASIA. For more details, see the PHAARMASIA quarterly results and PHAARMASIA share price and chart. For a sector overview, read our pharmaceuticals sector report.

PHAARMASIA Price History

Price Rs 39.8
Mkt Cap Rs m 272
Vol '000 0.5
P/E X 90.9
P/CF X 28.9
EPS (TTM) Rs 0.4
% ch % -0.3
No. of shares m 6.83
% ch week % 24.4
% ch 1-mth % 39.2
% ch 12-mth % 37.7
52 week H/L Rs 42.5/22.1
(As on Oct 14, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PHAARMASIA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
PHAARMASIA EQUITY SHARE DATA
High Rs3333503722 
Low Rs1114161410 
Sales per share (Unadj.) Rs31.612.727.733.335.8 
Earnings per share (Unadj.) Rs0.10.20.81.10.8 
Diluted earnings per shareRs0.10.20.81.10.8 
Cash flow per share (Unadj.) Rs0.80.91.51.81.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs17.417.117.618.819.6 
Adj. book value per shareRs17.417.117.618.819.6 
Shares outstanding (eoy) m6.836.836.836.836.83 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.71.81.20.80.5 
Avg P/E ratio x360.197.939.522.820.5 
P/CF ratio (eoy) x28.026.421.814.311.8 
Price / Book Value ratio x1.31.41.91.40.8 
Dividend payout %00000 
Avg Mkt Cap Rs m150159226177110 
No. of employees `000NANANANANA 
Total wages/salary Rs m1514171614 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
PHAARMASIA INCOME DATA
Net Sales Rs m21687190227245 
Other income Rs m56766 
Total revenues Rs m22192196233250 
Gross profit Rs m21578 
Depreciation Rs m54554 
Interest Rs m00000 
Profit before tax Rs m237810 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m21114 
Profit after tax Rs m02685 
Gross profit margin %1.01.52.63.23.3 
Effective tax rate %82.939.015.76.543.8 
Net profit margin %0.21.93.03.42.2 
PHAARMASIA BALANCE SHEET DATA
Current assets Rs m445675192199 
Current liabilities Rs m647191198195 
Net working cap to sales %-9.1-17.8-8.2-2.81.9 
Current ratio x0.70.80.81.01.0 
Inventory Days Days210544 
Debtors Days Days4915073189184 
Net fixed assets Rs m142140144141137 
Share capital Rs m6868686868 
"Free" reserves Rs m5048526066 
Net worth Rs m119117120128134 
Long term debt Rs m00100 
Total assets Rs m186195219333336 
Interest coverage x23.330.617.223.527.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.20.40.90.70.7 
Return on assets %0.30.92.82.41.7 
Return on equity %0.41.44.86.14.0 
Return on capital %2.22.35.96.87.4 
Exports to sales %00000 
Imports to sales %000.63.70 
Exports (fob) Rs m00000 
Imports (cif) Rs m00180 
Fx inflow Rs m00003 
Fx outflow Rs m00180 
Net fx Rs m00-1-83 
PHAARMASIA CASH FLOW
From Operations Rs m 3 -1 9 1 1 
From Investments Rs m -3 -2 -9 -1 0 
From Financial Activity Rs m 2 0 1 0 -1 
Net Cashflow Rs m 2 -3 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 73.5%
Institution 0.1%
Non-Institution 26.4%
Total 100.0%
Free Float 26.5%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 16 Phase 3, I D A, Jeedimetla, Hyderabad - 500055
E-MAIL phaarmasia@yahoo.com WEB www.phaarmasia.com
TEL 040-23095002 / 23095690 FAX 040-23097323
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
YEAR OF INC: 1981 BSE CODE: 523620 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   FORTIS MALAR  DECCAN HEALTH CARE  ADVIK LABORS  INDRAPRASTHA MEDICAL  CONCORD DRUGS  

Compare PHAARMASIA With:   FORTIS MALAR  DECCAN HEALTH CARE  ADVIK LABORS  INDRAPRASTHA MEDICAL  CONCORD DRUGS  




Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PHAARMASIA

  • Track your investment in PHAARMASIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PHAARMASIA

PHAARMASIA - AVON ORGANIC COMPARISON

COMPARE PHAARMASIA WITH

MARKET STATS